Combating Fungal Infections (Registro nro. 202080)

MARC details
000 -LÍDER
fixed length control field 05074nam a22005055i 4500
001 - NÚMERO DE CONTROL
control field u374200
003 - IDENTIFICADOR DEL NÚMERO DE CONTROL
control field SIRSI
005 - FECHA Y HORA DE LA ULTIMA TRANSACCIÓN
control field 20160812084222.0
007 - CAMPO FIJO DE DESCRIPCIÓN FIJA--INFORMACIÓN GENERAL
fixed length control field cr nn 008mamaa
008 - ELEMENTOS DE LONGITUD FIJA -- INFORMACIÓN GENERAL
fixed length control field 100803s2010 gw | s |||| 0|eng d
020 ## - NÚMERO INTERNACIONAL NORMALIZADO PARA LIBROS
International Standard Book Number 9783642121739
-- 978-3-642-12173-9
040 ## - FUENTE DE CATALOGACIÓN
Transcribing agency MX-MeUAM
050 #4 - SIGNATURA TOPOGRÁFICA DE LA BIBLIOTECA DEL CONGRESO
Classification number QR46
082 04 - NÚMERO DE CLASIFICACIÓN DECIMAL DEWEY
Classification number 616.9041
Edition number 23
100 1# - ASIENTO PRINCIPAL--NOMBRE PERSONAL
Personal name Ahmad, Iqbal.
Relator term editor.
245 10 - MENCIÓN DE TITULO
Title Combating Fungal Infections
Medium [recurso electrónico] :
Remainder of title Problems and Remedy /
Statement of responsibility, etc. edited by Iqbal Ahmad, Mohammad Owais, Mohammed Shahid, Farrukh Aqil.
250 ## - MENCIÓN DE EDICIÓN
Edition statement First.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Berlin, Heidelberg :
Name of producer, publisher, distributor, manufacturer Springer Berlin Heidelberg :
-- Imprint: Springer,
Date of production, publication, distribution, manufacture, or copyright notice 2010.
300 ## - DESCRIPCIÓN FÍSICA
Extent XX, 539 p.
Other physical details online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Encoding format PDF
Source rda
505 0# - NOTA DE CONTENIDO
Formatted contents note Mould Infections: A Global Threat to Immunocompromised Patients -- Virulence and Pathogenicity of Fungal Pathogens with Special Reference to Candida albicans -- Animal as Reservoir of Fungal Diseases (Zoonoses?) -- Fungi Associated with Eye Infections with Special Reference to Corneal Keratitis and Their Possible Reservoir -- Antifungal Drugs Mode of Action and Recent Development -- Antifungal-Induced Nephrotoxicity in Pediatrics: A State of the Art -- Antifungal Resistance: Cellular and Molecular Mechanisms -- Multidrug Resistance in Fungi: The Role of Pleiotropic Drug Resistance Genes -- Laboratory Diagnosis of Fungal Infections: An Overview -- Combinational Antifungal Therapy and Recent Trends in Drug Discovery -- Role of De-Escalation and Combination Therapy Strategies in the Management of Invasive Fungal Infection: A Multidisciplinary Point of View -- Challenges to the Management of Pulmonary Mycoses in Allogeneic Hematopoietic Stem Cell Transplantation -- Aspartic Peptidase Inhibitors as Potential Bioactive Pharmacological Compounds Against Human Fungal Pathogens -- Metabolic Pathways as Drug Targets: Targeting the Sulphur Assimilatory Pathways of Yeast and Fungi for Novel Drug Discovery -- Innate Immunity in Pathogenesis and Treatment of Dermatomycosis -- Cytokine Therapy: Possible Tools in Management of Fungal Infection -- Immunomodulators: Potential in Treatment of Systemic Fungal Infections -- Fungal Vaccines: Recent Trends -- Antifungal Activity of Medicinal Plant Extracts and Phytocompounds: A Review -- Novel Drug Delivery Systems for Antifungal Compounds.
520 ## - NOTA DE RESUMEN, ETC.
Summary, etc. The currently available means of combating fungal infections are still weak and clumsy. The application of fungal genomics offers an unparalleled opportunity to develop novel antifungal drugs. Interestingly, several novel antifungal drug targets have already been identified and validated. However, it is too early to expect any novel antifungal drug as drug discovery programs are still in their infancy. In addition to classical and genomic approaches to drug discovery, traditional knowledge derived from natural products and phytomedicine can provide a multitude of alternative modes of combating fungal infection. This book comprises 20 chapters on various aspects pertaining to fungal diseases in human and animals, their reservoir, fungal pathogenesis, their management and recent advances in their treatment. Issues of antifungal drug toxicity, especially nephrotoxicity, are also discussed. The development of resistance in fungal pathogens, including multidrug resistance and its mechanism, is dealt with in two chapters. Diverse diagnostic approaches to fungal infections are also reviewed. The combinational drug strategies used in combating invasive fungal infections are addressed in detail. The management of pulmonary mycoses in stem cell transplantation is also given special focus. Novel antifungal drugs (synthetic and herbal), fungal vaccines, and metabolic pathways as drug targets are discussed in detail in three different chapters. Subsequently the roles of innate immunity, cytokine therapy and immunomodulators in the treatment of fungal infections are elaborated upon. As novel drug delivery systems have a great potential for modifying the pharmacokinetics of medications, the last chapter takes this fact into consideration in its examination of state-of-the-art delivery systems in controlling fungal infections.
596 ## -
-- 19
650 #0 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Medicine.
650 #0 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Immunology.
650 #0 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Microbiology.
650 #0 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Toxicology.
650 14 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Biomedicine.
650 24 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Medical Microbiology.
650 24 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Microbiology.
650 24 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Immunology.
650 24 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO
Topical term or geographic name as entry element Pharmacology/Toxicology.
700 1# - ASIENTO SECUNDARIO - NOMBRE PERSONAL
Personal name Owais, Mohammad.
Relator term editor.
700 1# - ASIENTO SECUNDARIO - NOMBRE PERSONAL
Personal name Shahid, Mohammed.
Relator term editor.
700 1# - ASIENTO SECUNDARIO - NOMBRE PERSONAL
Personal name Aqil, Farrukh.
Relator term editor.
710 2# - ASIENTO SECUNDARIO - NOMBRE CORPORATIVO
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9783642121722
856 40 - LOCALIZACIÓN Y ACCESO ELECTRÓNICOS
Public note Libro electrónico
Uniform Resource Identifier <a href="http://148.231.10.114:2048/login?url=http://link.springer.com/book/10.1007/978-3-642-12173-9">http://148.231.10.114:2048/login?url=http://link.springer.com/book/10.1007/978-3-642-12173-9</a>
942 ## - TIPO DE MATERIAL (KOHA)
Koha item type Libro Electrónico
Existencias
Estado de retiro Fuente de clasificación Colección Ubicación permanente Ubicación actual Fecha de ingreso Total Checkouts Signatura topográfica Código de barras Date last seen Número de copia Tipo de material
    Colección de Libros Electrónicos Biblioteca Electrónica Biblioteca Electrónica     QR46 374200-2001 12/08/2016 1 Libro Electrónico

Con tecnología Koha